Company intelligence / Profile preview

Anatolia Geneworks

Istanbul, Istanbul, Turkey

Ownership: Private
Employees: ~109
Development stage: Other

Overview

Anatolia Geneworks has commercially launched a range of CE-marked Real-Time PCR kits for infectious disease diagnosis, with instruments and kits deployed globally; released an EU CE-marked COVID-19 detection kit in 2020

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: DeviceDiagnostic kitPCR-based test
Industry: Molecular Diagnostics

Partnerships

Launch Diagnostics (distribution/diagnostics partner in UK)

Beyond the preview

Go deeper on Anatolia Geneworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anatolia Geneworks.

Explore the full profile